Description
Product Overview / 商品概要
Dexamethasone Propionate Ointment 0.1% “MYK” (デキサメタゾンプロピオン酸エステル軟膏0.1%「MYK」)
Generic: Dexamethasone Propionate / デキサメタゾンプロピオン酸エステル
Therapeutic Category: Topical Synthetic Adrenocortical Hormone / 外用合成副腎皮質ホルモン剤
Manufactured by: MAE Co., Ltd. / 株式会社MAE
Composition & Specification / 組成・規格
Active Ingredient: Dexamethasone Propionate 1mg (0.1%) per 1g / 1g中 デキサメタゾンプロピオン酸エステル1mg(0.1%)
Additives: Polyoxyethylene hydrogenated castor oil 40, Propylene glycol, White petrolatum (contains dibutylhydroxytoluene as antioxidant) / ポリオキシエチレン硬化ヒマシ油40、プロピレングリコール、白色ワセリン(抗酸化剤としてジブチルヒドロキシトルエンを含む)
Appearance: White to slightly yellowish-white ointment with almost no odor
外観: ほとんどにおいのない白色~微黄白色の軟膏剤
Indications / 効能効果
EN: Eczema/dermatitis group (including progressive palmoplantar keratoderma, lichen Vidal, solar dermatitis), prurigo group (including urticaria-like lichen, strophulus, fixed urticaria), insect bites, drug eruption/toxic eruption, psoriasis, palmoplantar pustulosis, lichen planus, erythroderma, chronic discoid lupus erythematosus, erythema (erythema multiforme exudativum, Darier’s centrifugal annular erythema, centrifugal papular erythema), pityriasis rubra pilaris, idiopathic pigmented purpura (Majocchi’s purpura, Schamberg’s disease, pigmented purpuric lichenoid dermatitis), hypertrophic scar/keloid, granulomatosis (sarcoidosis, granuloma annulare), malignant lymphoma (including mycosis fungoides), lichen amyloidosis, macular amyloidosis, pemphigus group, familial benign chronic pemphigus, bullous pemphigoid, alopecia areata
JA: 湿疹・皮膚炎群(進行性指掌角皮症、ビダール苔癬、日光皮膚炎を含む)、痒疹群(蕁麻疹様苔癬、ストロフルス、固定蕁麻疹を含む)、虫さされ、薬疹・中毒疹、乾癬、掌蹠膿疱症、扁平紅色苔癬、紅皮症、慢性円板状エリテマトーデス、紅斑症(多形滲出性紅斑、ダリエ遠心性環状紅斑、遠心性丘疹性紅斑)、毛孔性紅色粃糠疹、特発性色素性紫斑(マヨッキー紫斑、シャンバーク病、紫斑性色素性苔癬様皮膚炎)、肥厚性瘢痕・ケロイド、肉芽腫症(サルコイドーシス、環状肉芽腫)、悪性リンパ腫(菌状息肉症を含む)、アミロイド苔癬、斑状アミロイドージス、天疱瘡群、家族性良性慢性天疱瘡、類天疱瘡、円形脱毛症
Dosage and Administration / 用法用量
EN: Usually, apply an appropriate amount to the affected area 1 to several times daily.
JA: 通常、1日1~数回、適量を患部に塗布する。
Contraindications / 禁忌
EN: Bacterial, fungal, spirochetal, or viral skin infections; history of hypersensitivity to any component of this product; eczematous otitis externa with perforated tympanic membrane; ulcers (excluding Behcet’s disease), deep second-degree or higher burns/frostbite
JA: 細菌・真菌・スピロヘータ・ウイルス皮膚感染症、本剤の成分に対し過敏症の既往歴のある患者、鼓膜に穿孔のある湿疹性外耳道炎、潰瘍(ベーチェット病は除く。)・第2度深在性以上の熱傷・凍傷
Regulatory Information / 規制情報
Approval No.: 30100AMX00094000
Sales Started: July 1995 / 1995年7月
Classification Code: 872646
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年
Packaging / 包装
Main Package (for sale): 5g x 50 (aluminum tubes) / 5g×50(アルミニウム製チューブ)
Other Available Packages (by special order): Aluminum tube: 5g x 50, Polyethylene container: 500g
Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.



![Ofloxacin Otic Solution 0.3% [CEO] (Ofloxacin Otic Solution CEO® / オフロキサシン耳科用液0.3%「CEO」)](https://jp-pharma.com/wp-content/uploads/2026/06/OFL-03-OTC_1200x1200-324x324.jpg)
Reviews
There are no reviews yet.